logo Research, Innovation and Dissemination Centers

Brazilian Research Institute for Neuroscience and Neurotechnology

CEPID 2013-2024

Website: www.brainn.org.br

Principal investigator: Fernando Cendes
Education and knowledge diffusion coordinator: Gabriela Castelhano
Technology transfer coordinator: Roberto José Maria Covolan

State University of Campinas (UNICAMP)
Faculdade de Ciência Médica
Laboratório de Neuroimagem
Rua Vital Brasil, 251 2º andar
13083-888 - Campinas, SP - Brasil

Center for Information Technology Renato Archer (CTI)
Centre National de la Recherche Scientifique (CNRS), France
Federal University of ABC (UFABC)
Federal University of São Paulo (UNIFESP)
Phillips University, Germany
São Paulo State University (UNESP)
University College London (UCL), United Kingdom
University of Erlangen, Germany
Université de Montréal, Canada

BV-FAPESP: research projects supported in this Center 

BRAINN in the Media: news about the Center


The Brazilian Research Institute for Neuroscience and Neurotechnology (BRAINN) studies epilepsy and stroke, and the injury mechanisms that follow disease onset and progression. This research has important applications regarding prevention, diagnosis, treatment, and rehabilitation, and will serve as a model for better understanding normal and abnormal brain function. The driving force of this RIDC came from the need to approach these relevant and complex biological problems by combining the expertise of research groups with distinct and complementary backgrounds.

One of the many aspects that demonstrate the characteristic complexity associated with research on epilepsy and stroke is the fact that such conditions are not uniquely defined, which means that these conditions cannot be traced to a single disease or a unique syndrome. Therefore, collaborative research needs to be conducted by scientists with expertise in a variety of fields, driven by solid scientific theories in order to provide relevant applications in the real world.

The Center’s research science seeks to be clinically important, realistic, and highly original, combining genetics, neurobiology, pharmacology, neuroimaging, computer sciences, robotics, physics, and engineering. Its outcome will benefit patients suffering from epilepsy, stroke, and other prevalent diseases and will substantially contribute to ongoing scientific discussions within the areas of neurology, psychiatry, and cognitive neuroscience.

The proposed collaboration between BRAINN and other major neuroscience groups will further advance the knowledge that is directly relevant to all who suffer from these devastating neurological conditions.